InvestorsHub Logo
Followers 43
Posts 2607
Boards Moderated 0
Alias Born 05/21/2006

Re: Amatuer17 post# 2493

Monday, 06/29/2020 10:30:09 AM

Monday, June 29, 2020 10:30:09 AM

Post# of 2676
Welcome to the board Amateur17. Great post, and spot on in my opinion. I completely agree that ASD gives ZYNE the best potential for highest stock price. Fragile X is the nearest term catalyst though, as you are aware. Even though FX is far more rare than ASD, the opportunity to be "first in class" is huge. Good top line results in the FX trial and this stock is off to the races immediately. Honestly, my biggest fear at the moment....bigger even than getting bad results in clinical trials (because I dont think we will)....is a buyout. GWPH is already nuts for not trying to buy ZYNE already, unless they have but didn't make it public knowledge. If they made an offer of $20 a share right now, it would be difficult for management to turn down. I don't think they would offer $20 per share, and yet it's way too low. I do fear a buyout capping the ultimate potential here. If ZYNE can avoid being bought out, there's no doubt this can be a $100 stock if the results are good in all phase III trials. $100 is even cheap.....

Exciting times to be a ZYNE shareholder
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News